Molecure S.A.
MOC.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.79 | 0.34 | -0.09 | 0.32 |
| FCF Yield | -39.58% | -7.20% | -21.91% | -6.20% |
| EV / EBITDA | -7.05 | -10.64 | -4.42 | -31.94 |
| Quality | ||||
| ROIC | -29.75% | -29.06% | -30.85% | -9.24% |
| Gross Margin | -16.78% | -4,101,610.00% | -0.28% | -693,272.50% |
| Cash Conversion Ratio | 1.82 | 0.82 | 0.67 | 0.99 |
| Growth | ||||
| Revenue 3-Year CAGR | -27.03% | -37.00% | -60.61% | -47.77% |
| Free Cash Flow Growth | -241.47% | 46.05% | -35.61% | -158.41% |
| Safety | ||||
| Net Debt / EBITDA | 0.40 | 2.23 | 1.86 | 7.20 |
| Interest Coverage | -356.66 | -360.18 | -2,684.38 | -2,123.46 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 3,594.89 | 34,906.60 | -629.59 | 12,268,699.97 |